FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2070046033> ?p ?o ?g. }

• W2070046033 endingPage "245" @default.
• W2070046033 startingPage "236" @default.
• W2070046033 abstract "Recently, clinical trials of several neurodegenerative diseases have increasingly targeted the evaluation of the effectiveness of various antioxidants. The results so far are encouraging but variable and thus confusing. Rationale for the possible clinical effectiveness of antioxidants in several degenerative conditions has arisen out of the many years of basic science generally showing that reactive oxygen species (ROS) and oxidative damage are important factors in the processes involved. Aging is one of the most significant risk factors for degenerative neurological disorders. Basic science efforts in our laboratory have centered on exploring the role of ROS and oxidative stress in neurodegenerative processes. The present review brings together some of the basic concepts we have learned by following this approach for the last 20 years and specifically the results we have obtained by following up on our serendipitous findings that a nitrone-based free radical trap, alpha-phenyl-tert-butylnitrone (PBN), has neuroprotective activity in several experimental neurodegenerative models. The mechanistic basis of the neuroprotective activity of PBN does not appear to rely on its general free radical trapping or antioxidant activity per se, but its activity in mediating the suppression of genes induced by pro-inflammatory cytokines and other mediators associated with enhanced neuroinflammatory processes. Neuroinflammatory processes, induced in part by pro-inflammatory cytokines, yield enhanced ROS and reactive nitric oxide species (RNS) as well as other unknown components that have neurotoxic properties. Neurotoxic amounts of RNS are formed by the activity of inducible nitric oxide synthase (iNOS). The demonstration of enhanced 3-nitro-tyrosine formation in affected regions of the Alzheimer's brain, in comparison to age-matched controls, reinforces the importance of neuroinflammatory processes. iNOS induction involves activation by phosphorylation of the MAP kinase p38 and can be induced in cultured astrocytes by IL-1beta or H2O2. The action of PBN and N-acetyl cysteine to suppress the activation of p38 was demonstrated in cultured astrocytes. The demonstration of activated p38 in neurons surrounding amyloid plaques in affected regions of the Alzheimer's brain attest to enhanced signal transduction processes in this neurodegenerative condition. The major themes of ROS and RNS formation associated with neuroinflammation processes and the suppression of these processes by antioxidants and PBN continue to yield promising leads for new therapies. Outcomes of clinical trials on antioxidants will become less confusing as more knowledge is amassed on the basic processes involved." @default.
• W2070046033 created "2016-06-24" @default.
• W2070046033 creator A5046466118 @default.
• W2070046033 date "1999-12-01" @default.
• W2070046033 modified "2023-10-16" @default.
• W2070046033 title "Antioxidants, Oxidative Stress, and Degenerative Neurological Disorders" @default.
• W2070046033 cites W1606988289 @default.
• W2070046033 cites W1745925983 @default.
• W2070046033 cites W1974003379 @default.
• W2070046033 cites W1974182326 @default.
• W2070046033 cites W1974198922 @default.
• W2070046033 cites W1976271098 @default.
• W2070046033 cites W1978828915 @default.
• W2070046033 cites W1979470828 @default.
• W2070046033 cites W1982054375 @default.
• W2070046033 cites W1982386154 @default.
• W2070046033 cites W1985221375 @default.
• W2070046033 cites W1986740549 @default.
• W2070046033 cites W1988726352 @default.
• W2070046033 cites W1999220416 @default.
• W2070046033 cites W2023105087 @default.
• W2070046033 cites W2026995847 @default.
• W2070046033 cites W2027317604 @default.
• W2070046033 cites W2032085425 @default.
• W2070046033 cites W2035271664 @default.
• W2070046033 cites W2046242053 @default.
• W2070046033 cites W2049189117 @default.
• W2070046033 cites W2054360287 @default.
• W2070046033 cites W2059640915 @default.
• W2070046033 cites W2065264404 @default.
• W2070046033 cites W2065922141 @default.
• W2070046033 cites W2077512485 @default.
• W2070046033 cites W2094978651 @default.
• W2070046033 cites W2095450169 @default.
• W2070046033 cites W2104194752 @default.
• W2070046033 cites W2132826785 @default.
• W2070046033 cites W2140841363 @default.
• W2070046033 cites W2142084940 @default.
• W2070046033 cites W2202491923 @default.
• W2070046033 cites W226259664 @default.
• W2070046033 cites W2278726608 @default.
• W2070046033 cites W2301404923 @default.
• W2070046033 cites W2326200998 @default.
• W2070046033 cites W2735705544 @default.
• W2070046033 cites W31423640 @default.
• W2070046033 doi "https://doi.org/10.1046/j.1525-1373.1999.d01-140.x" @default.
• W2070046033 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10601882" @default.
• W2070046033 hasPublicationYear "1999" @default.
• W2070046033 type Work @default.
• W2070046033 sameAs 2070046033 @default.
• W2070046033 citedByCount "784" @default.
• W2070046033 countsByYear W20700460332012 @default.
• W2070046033 countsByYear W20700460332013 @default.
• W2070046033 countsByYear W20700460332014 @default.
• W2070046033 countsByYear W20700460332015 @default.
• W2070046033 countsByYear W20700460332016 @default.
• W2070046033 countsByYear W20700460332017 @default.
• W2070046033 countsByYear W20700460332018 @default.
• W2070046033 countsByYear W20700460332019 @default.
• W2070046033 countsByYear W20700460332020 @default.
• W2070046033 countsByYear W20700460332021 @default.
• W2070046033 countsByYear W20700460332022 @default.
• W2070046033 countsByYear W20700460332023 @default.
• W2070046033 crossrefType "journal-article" @default.
• W2070046033 hasAuthorship W2070046033A5046466118 @default.
• W2070046033 hasConcept C126322002 @default.
• W2070046033 hasConcept C142724271 @default.
• W2070046033 hasConcept C169760540 @default.
• W2070046033 hasConcept C185592680 @default.
• W2070046033 hasConcept C25498285 @default.
• W2070046033 hasConcept C2776151105 @default.
• W2070046033 hasConcept C2776925932 @default.
• W2070046033 hasConcept C2777622882 @default.
• W2070046033 hasConcept C2778004101 @default.
• W2070046033 hasConcept C2779134260 @default.
• W2070046033 hasConcept C2779525624 @default.
• W2070046033 hasConcept C48349386 @default.
• W2070046033 hasConcept C519581460 @default.
• W2070046033 hasConcept C55493867 @default.
• W2070046033 hasConcept C71924100 @default.
• W2070046033 hasConcept C86803240 @default.
• W2070046033 hasConcept C98274493 @default.
• W2070046033 hasConceptScore W2070046033C126322002 @default.
• W2070046033 hasConceptScore W2070046033C142724271 @default.
• W2070046033 hasConceptScore W2070046033C169760540 @default.
• W2070046033 hasConceptScore W2070046033C185592680 @default.
• W2070046033 hasConceptScore W2070046033C25498285 @default.
• W2070046033 hasConceptScore W2070046033C2776151105 @default.
• W2070046033 hasConceptScore W2070046033C2776925932 @default.
• W2070046033 hasConceptScore W2070046033C2777622882 @default.
• W2070046033 hasConceptScore W2070046033C2778004101 @default.
• W2070046033 hasConceptScore W2070046033C2779134260 @default.
• W2070046033 hasConceptScore W2070046033C2779525624 @default.
• W2070046033 hasConceptScore W2070046033C48349386 @default.
• W2070046033 hasConceptScore W2070046033C519581460 @default.
• W2070046033 hasConceptScore W2070046033C55493867 @default.
• W2070046033 hasConceptScore W2070046033C71924100 @default.
• W2070046033 hasConceptScore W2070046033C86803240 @default.

• next